As Founding Partner of Tungsten, Romy brings experience from academia, private equity, start-ups, and investment banking.
Romy also serves as a Scientist Reviewer for the Cancer Prevention Research Institute of Texas (CPRIT), a state agency with a $6 Billion fund to invest in innovative cancer research and an advisor to Audaz Capital, a venture fund representing the Hunt family’s venture interests.
Additionally, Romy is also a Director on the Board of iPill Dispenser, a tech enabled device company to improve treatment compliance in patients with Opioid Use Disorder.
Romy started his career as an Engineer in the Biosciences Division at the National Aeronautics and Space Administration (NASA).
After NASA, Romy was an Investment Analyst at a private equity firm with $200 Million of assets under management, Prism Capital, where he conducted valuations, diligence on new opportunities and worked with companies to develop operational strategy, conduct market research, and review potential acquisitions and/or strategic partnerships.
After Prism, Romy was a Vice President at Ferghana Partners, a global boutique life science Investment Bank, where he completed mergers and acquisitions, corporate partnering and financing transactions for early/mid-stage therapeutics, diagnostics and medical device companies with an aggregate transaction value of $1 Billion.
Romy also co-founded Medinas Health, a marketplace for medical supplies and equipment. The company raised its first round of capital from General Catalyst, second round from NfX, won the WeWork Global Creator Awards and completed Y Combinator’s Program.
During Romy’s academic training, he completed a double degree (engineering and science) and conducted mathematical modeling research in space flight anemia with the Canadian Space Agency. Romy also completed basic science research in tissue engineering using inducible pluripotent stem cells, tubular kidney injury and clinical research in occupational asthma at the University of Toronto. As a result of his research, Romy published several peer-reviewed manuscripts, abstracts, posters and also had two of his experiments fly on the International Space Station through NASA.
EDUCATION + CERTIFICATION
BASc in Chemical Engineering with a minor in Bioengineering from the University of Toronto.
BSc in Human Biology and Toxicology from the University of Toronto.
Mr. Seth holds FINRA licenses: Securities Industry Essentials, Series 63 and Series 79.
Mr. Seth is Registered Representative of Finalis Securities LLC Member FINRA/SIPC.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Have a lightbulb moment with us
Sign up for updates from Tungsten
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.